Industry News
Pharmaceutical Industry News
The company will work with new…
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
AstraZeneca and Daiichi Sankyo’s…
AstraZeneca and Daiichi Sankyo’s Datroway has become the first cancer drug to show an overall survival benefit against chemotherapy for certain patients with a particularly aggressive form of breast cancer. In a phase 3 trial,
Myeloid Therapeutics’ name no…
Myeloid Therapeutics’ name no longer fits its pipeline. Having expanded beyond the eponymous myeloid cells, the biotech has rebranded as Create Medicines and committed to an R&D strategy that spans in vivo multi-immune programming.
What to Know as Gisèle Pelicot Returns to Court for Man’s Appeal
The Frenchwoman who became a feminist icon will confront one of the men convicted after her husband drugged her and invited them to rape her over nearly 10 years.
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs
Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website.
Why Brittle Bones Aren’t Just a Woman’s Problem
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
How Private Equity Oversees the Ethics of Drug Research
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.
Rite Aid Closes Its Remaining Stores
The company said it had closed its remaining 89 stores this week after struggling for years to stay in business and filing for bankruptcy protection twice.
Katie Carr of Swoop discusses…
Katie Carr of Swoop discusses evolving privacy laws, TV’s role in patient trust and the future of in-house measurement
The FDA unveiled a new pilot…
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry stakeholders this week
Patients and providers often enter…
Patients and providers often enter the exam room misaligned. A 360° data strategy may be pharma’s missing link.
OptimizeRx CEO highlights earlier…
OptimizeRx CEO highlights earlier diagnosis, smarter strategies
In a letter inked to the U.K.’s…
In a letter inked to the U.K.’s Competition and Markets Authority, three advocacy organizations called the recent string of Big Pharma companies pulling their U.K. investments a coordinated scheme for "anti-competitive purposes."
The FDA has approved Jazz…
The FDA has approved Jazz Pharmaceuticals’ Zepzelca, used in combination with Roche’s Tecentriq, as a first-line maintenance treatment in extensive-stage small cell lung cancer
The initial part of the up-to-$339…
The initial part of the up-to-$339 million funding will largely be used to establish U.S. manufacturing for the non-vaccine flu preventive candidate, with additional options tied to further clinical studies, Cidara said.
GSK has successfully appealed…
GSK has successfully appealed a ruling by the U.K. marketing watchdog that determined a trio of its COVID-19 vaccine press releases had brought discredit on the pharma industry.
Sealed court documents obtained by…
Sealed court documents obtained by Fierce Biotech reveal how Novo Nordisk and Singapore's KBP Biosciences went from partners in a $1.3 billion deal to legal foes. Takeda has decided to cease all research work in
Artificial intelligence is…
Artificial intelligence is redefining industries at an unprecedented pace—and healthcare is no exception. But as algorithms grow smarter and adoption accelerates, leaders face a pressing question: how do we embrace the possibilities of AI without
Vaxcyte is paying Thermo Fisher…
Vaxcyte is paying Thermo Fisher Scientific up to $1 billion to access vaccine fill-finish capacity at the CDMO’s production facility in Greenville, North Carolina. Vaxcyte positioned the deal as a “long-term U.S. commercial manufacturing commitment.”
Chris Paquette sees data…
Chris Paquette sees data integration, personalization and cross-team alignment reshaping the industry